{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:11:27Z","timestamp":1791720687391,"version":"4.3.4"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To assess gender differences in ankylosing spondylitis (<jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>) patients in relation to tumor necrosis factor alpha inhibitor (<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i) drug survival and occurrence of adverse events in daily practice in a large peripheral hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Retrospective data were collected from <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> patients treated with etanercept, infliximab and adalimumab between January 2004 and January 2014. Kaplan\u2013Meier survival curves were conducted to describe the drug survival and occurrence of adverse events in time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 122 <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> patients (60.7% male) were included over a 10\u2010year time period, with a mean treatment period of 51 months (1\u2013127 months). In total, 21 (17.2%) patients stopped the <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i, mainly due to inefficacy (52.4%). Female patients showed a significant shorter treatment period compared to males (33.4 <jats:italic>vs<\/jats:italic>. 44.9 months). In addition, female patients switched more between <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i compared to males (26.9% <jats:italic>vs<\/jats:italic>. 16.3%) and had a significantly higher risk at developing infections compared to male patients (26% <jats:italic>vs<\/jats:italic>.19%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Females stayed on the same <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i for a significantly shorter period compared to males (33.4 <jats:italic>vs<\/jats:italic>. 44.9 months) and the most important reason to stop or switch the drug was inefficacy. Moreover, females seemed to be more prone to infections during <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i treatment than males.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1756-185x.13271","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T05:04:37Z","timestamp":1522991077000},"page":"836-842","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice"],"prefix":"10.1111","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8628-0119","authenticated-orcid":false,"given":"Tamara","family":"Rusman","sequence":"first","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center Department of Rheumatology VU University Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"ten Wolde","sequence":"additional","affiliation":[{"name":"Spaarne Gasthuis Haarlem Haarlem The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd M.","family":"Euser","sequence":"additional","affiliation":[{"name":"Regional Laboratory of Public Health Kennemerland Haarlem Haarlem The Netherlands"},{"name":"Spaarne Gasthuis Academie Haarlem The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd","family":"van der Ploeg","sequence":"additional","affiliation":[{"name":"Spaarne Medical Centre Alkmaar Haarlem The Netherlands"},{"name":"Spaarne Gasthuis Academie Haarlem The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"van Hall","sequence":"additional","affiliation":[{"name":"Slotervaart Hospital Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene E.","family":"van der Horst\u2010Bruinsma","sequence":"additional","affiliation":[{"name":"Amsterdam Rheumatology and Immunology Center Department of Rheumatology VU University Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197510232931701"},{"key":"e_1_2_7_3_1","first-page":"1649","article-title":"Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men","volume":"17","author":"Will R","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60635-7"},{"key":"e_1_2_7_5_1","volume-title":"Education and learning for people with ankylosing spondylitis","author":"Thompson B","year":"2011"},{"issue":"6","key":"e_1_2_7_6_1","first-page":"S67","article-title":"Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs","volume":"20","author":"van der Horst\u2010Bruinsma IE","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_7_1","first-page":"1346","article-title":"Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long\u2010term safety and efficacy for ankylosing spondylitis (ATLAS)","volume":"35","author":"Revicki DA","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep422"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111337"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087270"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes026"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202431"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.124446"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0130-0"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-77"},{"key":"e_1_2_7_16_1","unstructured":"NVvR (NVR). (2011)Richtlijn verantwoord gebruik van biologicals."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2772-6"},{"issue":"5","key":"e_1_2_7_18_1","first-page":"S188","article-title":"A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases","volume":"23","author":"Kvien TK","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3369"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-015-0620-4"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201933"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4258"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken334"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(00)00027-0"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.11.013"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi008"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2394"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2011.01052.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20258"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-139X(01)00382-2"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2471"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.05.003"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.08.006"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.05.004"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2010.02332.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2011-200954rep"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140353"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3381-3"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.13271","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:15:49Z","timestamp":1695568549000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.13271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1111\/1756-185X.13271"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.13271","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"2018-04-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}